PMID- 10027409 OWN - NLM STAT- MEDLINE DCOM- 19990304 LR - 20231105 IS - 0002-9440 (Print) IS - 1525-2191 (Electronic) IS - 0002-9440 (Linking) VI - 154 IP - 2 DP - 1999 Feb TI - Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. PG - 515-23 AB - Overexpression of cell surface glycoproteins of the CD44 family is an early event in the colorectal adenoma-carcinoma sequence. This suggests a link with disruption of APC tumor suppressor protein-mediated regulation of beta-catenin/Tcf-4 signaling, which is crucial in initiating tumorigenesis. To explore this hypothesis, we analyzed CD44 expression in the intestinal mucosa of mice and humans with genetic defects in either APC or Tcf-4, leading to constitutive activation or blockade of the beta-catenin/Tcf-4 pathway, respectively. We show that CD44 expression in the non-neoplastic intestinal mucosa of Apc mutant mice is confined to the crypt epithelium but that CD44 is strongly overexpressed in adenomas as well as in invasive carcinomas. This overexpression includes the standard part of the CD44 (CD44s) as well as variant exons (CD44v). Interestingly, deregulated CD44 expression is already present in aberrant crypt foci with dysplasia (ACFs), the earliest detectable lesions of colorectal neoplasia. Like ACFs of Apc-mutant mice, ACFs of familial adenomatous polyposis (FAP) patients also overexpress CD44. In sharp contrast, Tcf-4 mutant mice show a complete absence of CD44 in the epithelium of the small intestine. This loss of CD44 concurs with loss of stem cell characteristics, shared with adenoma cells. Our results indicate that CD44 expression is part of a genetic program controlled by the beta-catenin/Tcf-4 signaling pathway and suggest a role for CD44 in the generation and turnover of epithelial cells. FAU - Wielenga, V J AU - Wielenga VJ AD - Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands. FAU - Smits, R AU - Smits R FAU - Korinek, V AU - Korinek V FAU - Smit, L AU - Smit L FAU - Kielman, M AU - Kielman M FAU - Fodde, R AU - Fodde R FAU - Clevers, H AU - Clevers H FAU - Pals, S T AU - Pals ST LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Am J Pathol JT - The American journal of pathology JID - 0370502 RN - 0 (CTNNB1 protein, human) RN - 0 (CTNNB1 protein, mouse) RN - 0 (Cytoskeletal Proteins) RN - 0 (DNA Primers) RN - 0 (DNA, Neoplasm) RN - 0 (Hyaluronan Receptors) RN - 0 (Proto-Oncogene Proteins) RN - 0 (RNA, Messenger) RN - 0 (TCF Transcription Factors) RN - 0 (TCF7L2 protein, human) RN - 0 (Tcf7l2 protein, mouse) RN - 0 (Trans-Activators) RN - 0 (Transcription Factor 7-Like 2 Protein) RN - 0 (Transcription Factors) RN - 0 (Wnt Proteins) RN - 0 (Zebrafish Proteins) RN - 0 (beta Catenin) SB - IM MH - Adenoma/metabolism/pathology MH - Adenomatous Polyposis Coli/genetics/metabolism/pathology MH - Adult MH - Animals MH - Carcinoma/metabolism/pathology MH - Cytoskeletal Proteins/genetics/*metabolism MH - DNA Primers/chemistry MH - DNA, Neoplasm/analysis MH - Female MH - Fluorescent Antibody Technique, Indirect MH - Genes, APC/*genetics MH - Humans MH - Hyaluronan Receptors/analysis/*biosynthesis MH - Intestinal Mucosa/metabolism/pathology MH - Intestinal Neoplasms/metabolism/pathology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Mutant Strains MH - Proto-Oncogene Proteins/*metabolism MH - RNA, Messenger/biosynthesis MH - Reverse Transcriptase Polymerase Chain Reaction MH - Signal Transduction MH - TCF Transcription Factors MH - *Trans-Activators MH - Transcription Factor 7-Like 2 Protein MH - Transcription Factors/*genetics MH - Wnt Proteins MH - *Zebrafish Proteins MH - beta Catenin PMC - PMC1850011 EDAT- 1999/02/23 00:00 MHDA- 1999/02/23 00:01 PMCR- 1999/08/01 CRDT- 1999/02/23 00:00 PHST- 1999/02/23 00:00 [pubmed] PHST- 1999/02/23 00:01 [medline] PHST- 1999/02/23 00:00 [entrez] PHST- 1999/08/01 00:00 [pmc-release] AID - S0002-9440(10)65297-2 [pii] AID - 1592 [pii] AID - 10.1016/S0002-9440(10)65297-2 [doi] PST - ppublish SO - Am J Pathol. 1999 Feb;154(2):515-23. doi: 10.1016/S0002-9440(10)65297-2.